Keyphrases
Therapeutic Strategies
100%
Novel Biomarkers
100%
Biomarker Strategy
100%
Triple-negative Breast Cancer
100%
Novel Therapeutics
100%
Annexin A2 (ANXA2)
66%
Human Epidermal Growth Factor Receptor 2 (HER2)
20%
Therapeutic Target
20%
African American Women
20%
Breast Cancer Patients
13%
Novel Therapies
6%
Putative Biomarkers
6%
Chemoresistance
6%
Cancer Cell Proliferation
6%
Herceptin
6%
Specific Biomarkers
6%
Health Disparities
6%
Downstream Signaling
6%
Breast Cancer
6%
High Mortality Rate
6%
Cancer Cell Migration
6%
Treatment Regimen
6%
Prognostic Factors
6%
Proliferation Migration
6%
Diagnostic Biomarker
6%
Successful Completion
6%
Chemotherapy
6%
Primary Prevention
6%
Overexpression
6%
Proposed Work
6%
Progesterone Receptor
6%
Signaling Pathway
6%
Cancer Invasion
6%
Estrogen Receptor
6%
Specific Intent
6%
Program Targeting
6%
Biochemistry, Genetics and Molecular Biology
Annexin A2
100%
Cell Invasion
33%
Epidermal Growth Factor Receptor
33%
Cancer Cell
33%
Cell Migration
33%
Trastuzumab
33%
Mortality Rate
33%
Progesterone Receptor
33%
Drug Resistance
33%
Health Disparity
33%
Estrogen Receptor Beta
33%
Cell Proliferation
33%
Diagnostic Biomarker
33%